TNF-like ligand 1A (TL1A) gene knockout leads to ameliorated collagen-induced arthritis in mice: Implication of TL1A in humoral immune responses

Journal of Immunology

Volumn 191, Issue 11, 2013, Pages 5420-5429

  Wang, Xuehai ^a   Hu, Yan ^a   Charpentier, Tania ^b   Lamarre, Alain ^b   Qi, Shijie ^a   Wu, Jiangping ^a   Luo, Hongyu ^a  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b INRS INSTITUT ARMAND FRAPPIER   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; COLLAGEN ANTIBODY; DEATH RECEPTOR 3; VASCULAR ENDOTHELIAL GROWTH INHIBITOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY TITER; ARTICLE; B LYMPHOCYTE; FEMALE; HISTOPATHOLOGY; HUMORAL IMMUNITY; IN VITRO STUDY; IN VIVO STUDY; KNOCKOUT MOUSE; LYMPHOID CELL; MALE; MORBIDITY; MOUSE; NONHUMAN; ORGAN SIZE; PLASMA CELL; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; RHEUMATOID ARTHRITIS; T LYMPHOCYTE SUBPOPULATION; WILD TYPE;

EID: 84888385081     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1301475     Document Type: Article

References (51)

1. Migone, T. S., J. Zhang, X. Luo, L. Zhuang, C. Chen, B. Hu, J. S. Hong, J. W. Perry, S. F. Chen, J. X. H. Zhou, et al. 2002. TL1A is a TNF-like ligand for DR3 and TR6/DcR3 and functions as a T cell costimulator. Immunity 16: 479-492.
2. Bamias, G., M. Mishina, M. Nyce, W. G. Ross, G. Kollias, J. Rivera-Nieves, T. T. Pizarro, and F. Cominelli. 2006. Role of TL1A and its receptor DR3 in two models of chronic murine ileitis. Proc. Natl. Acad. Sci. USA 103: 8441-8446.
3. Fang, L., B. Adkins, V. Deyev, and E. R. Podack. 2008. Essential role of TNF receptor superfamily 25 (TNFRSF25) in the development of allergic lung inflammation. J. Exp. Med. 205: 1037-1048.
4. Takedatsu, H., K. S. Michelsen, B. Wei, C. J. Landers, L. S. Thomas, D. Dhall, J. Braun, and S. R. Targan. 2008. TL1A (TNFSF15) regulates the development of chronic colitis by modulating both T-helper 1 and T-helper 17 activation. Gastroenterology 135: 552-567.
5. Zhang, J., X. Wang, H. Fahmi, S. Wojcik, J. Fikes, Y. Yu, J. Wu, and H. Luo. 2009. Role of TL1A in the pathogenesis of rheumatoid arthritis. J. Immunol. 183: 5350-5357.
6. Prehn, J. L., S. Mehdizadeh, C. J. Landers, X. Luo, S. C. Cha, P. Wei, and S. R. Targan. 2004. Potential role for TL1A, the new TNF-family member and potent costimulator of IFN-γ, in mucosal inflammation. Clin. Immunol. 112: 66-77.
7. Kim, S., and L. Zhang. 2005. Identification of naturally secreted soluble form of TL1A, a TNF-like cytokine. J. Immunol. Methods 298: 1-8.
8. Biener-Ramanujan, E., R. Gonsky, B. Ko, and S. R. Targan. 2010. Functional signaling of membrane-bound TL1A induces IFN-γ expression. FEBS Lett. 584: 2376-2380.
9. Meylan, F., Y.-J. Song, I. Fuss, S. Villarreal, E. Kahle, I.-J. Malm, K. Acharya, H. L. Ramos, L. Lo, M. M. Mentink-Kane, et al. 2011. The TNF-family cytokine TL1A drives IL-13?dependent small intestinal inflammation. Mucosal Immunol. 4: 172-185.
10. Wang, E. C., J. Kitson, A. Thern, J. Williamson, S. N. Farrow, and M. J. Owen. 2001. Genomic structure, expression, and chromosome mapping of the mouse homologue for the WSL-1 (DR3, Apo3, TRAMP, LARD, TR3, TNFRSF12) gene. Immunogenetics 53: 59-63.
11. Bu, R., C. W. Borysenko, Y. Li, L. Cao, A. Sabokbar, and H. C. Blair. 2003. Expression and function of TNF-family proteins and receptors in human osteoblasts. Bone 33: 760-770.
12. Al-Lamki, R. S., J. Wang, A. M. Tolkovsky, J. A. Bradley, J. L. Griffin, S. Thiru, E. C. Y. Wang, E. Bolton, W. Min, P. Moore, et al. 2008. TL1A both promotes and protects from renal inflammation and injury. J. Am. Soc. Nephrol. 19: 953-960.
13. Craxton, A., G. Shu, J. D. Graves, J. Saklatvala, E. G. Krebs, and E. A. Clark. 1998. p38 MAPK is required for CD40-induced gene expression and proliferation in B lymphocytes. J. Immunol. 161: 3225-3236.
14. Screaton, G. R., X. N. Xu, A. L. Olsen, A. E. Cowper, R. Tan, A. J. McMichael, and J. I. Bell. 1997. LARD: a new lymphoid-specific death domain containing receptor regulated by alternative pre-mRNA splicing. Proc. Natl. Acad. Sci. USA 94: 4615-4619.
15. Meylan, F., T. S. Davidson, E. Kahle, M. Kinder, K. Acharya, D. Jankovic, V. Bundoc, M. Hodges, E. M. Shevach, A. Keane-Myers, et al. 2008. The TNF-family receptor DR3 is essential for diverse T cell?mediated inflammatory diseases. Immunity 29: 79-89.
16. Papadakis, K. A., J. L. Prehn, C. Landers, Q. Han, X. Luo, S. C. Cha, P. Wei, and S. R. Targan. 2004. TL1A synergizes with IL-12 and IL-18 to enhance IFN-γ production in human T cells and NK cells. J. Immunol. 172: 7002-7007.
17. Bamias, G., C. Martin, III, M. Marini, S. Hoang, M. Mishina, W. G. Ross, M. A. Sachedina, C. M. Friel, J. Mize, S. J. Bickston, et al. 2003. Expression, localization, and functional activity of TL1A, a novel Th1-polarizing cytokine in inflammatory bowel disease. J. Immunol. 171: 4868-4874.
18. Bamias, G., S. I. Siakavellas, K. S. Stamatelopoulos, E. Chryssochoou, C. Papamichael, and P. P. Sfikakis. 2008. Circulating levels of TNF-like cytokine 1A (TL1A) and its decoy receptor 3 (DcR3) in rheumatoid arthritis. Clin. Immunol. 129: 249-255.
19. Bamias, G., G. Kaltsa, S. I. Siakavellas, K. Papaxoinis, E. Zampeli, S. Michopoulos, I. Zouboulis-Vafiadis, and S. D. Ladas. 2010. High intestinal and systemic levels of decoy receptor 3 (DcR3) and its ligand TL1A in active ulcerative colitis. Clin. Immunol. 137: 242-249.
20. Taraban, V. Y., T. J. Slebioda, J. E. Willoughby, S. L. Buchan, S. James, B. Sheth, N. R. Smyth, G. J. Thomas, E. C. Y. Wang, and A. Al-Shamkhani. 2011. Sustained TL1A expression modulates effector and regulatory T-cell responses and drives intestinal goblet cell hyperplasia. Mucosal Immunol. 4: 186-196.
21. Shih, D. Q., R. Barrett, X. Zhang, N. Yeager, H. W. Koon, P. Phaosawasdi, Y. Song, B. Ko, M. H. Wong, K. S. Michelsen, et al. 2011. Constitutive TL1A (TNFSF15) expression on lymphoid or myeloid cells leads to mild intestinal inflammation and fibrosis. PLoS One 6: e16090.
22. Pappu, B. P., A. Borodovsky, T. S. Zheng, X. Yang, P. Wu, X. Dong, S. Weng, B. Browning, M. L. Scott, L. Ma, et al. 2008. TL1A-DR3 interaction regulates Th17 cell function and Th17-mediated autoimmune disease. J. Exp. Med. 205: 1049-1062.
23. Bull, M. J., A. S. Williams, Z. Mecklenburgh, C. J. Calder, J. P. Twohig, C. Elford, B. A. J. Evans, T. F. Rowley, T. J. Slebioda, V. Y. Taraban, et al. 2008. The death receptor 3-TNF-like protein 1A pathway drives adverse bone pathology in inflammatory arthritis. J. Exp. Med. 205: 2457-2464.
24. Twohig, J. P., M. Marsden, S. M. Cuff, J. R. Ferdinand, A. M. Gallimore, W. V. Perks, A. Al-Shamkhani, I. R. Humphreys, and E. C. Y. Wang. 2012. The death receptor 3/TL1A pathway is essential for efficient development of antiviral CD4+ and CD8+ T-cell immunity. FASEB J. 26: 3575-3586.
25. Buchan, S. L., V. Y. Taraban, T. J. Slebioda, S. James, A. F. Cunningham, and A. Al-Shamkhani. 2012. Death receptor 3 is essential for generating optimal protective CD4+ T-cell immunity against Salmonella. Eur. J. Immunol. 42: 580-588.
26. Gay, S., R. E. Gay, and W. J. Koopman. 1993. Molecular and cellular mechanisms of joint destruction in rheumatoid arthritis: two cellular mechanisms explain joint destruction? Ann. Rheum. Dis. 52(Suppl. 1): S39-S47.
27. van der Heijden, I. M., B. Wilbrink, I. Tchetverikov, I. A. Schrijver, L. M. Schouls, M. P. Hazenberg, F. C. Breedveld, and P. P. Tak. 2000. Presence of bacterial DNA and bacterial peptidoglycans in joints of patients with rheumatoid arthritis and other arthritides. Arthritis Rheum. 43: 593-598.
28. Mauri, C., and M. R. Ehrenstein. 2007. Cells of the synovium in rheumatoid arthritis. B cells. Arthritis Res. Ther. 9: 205.
29. Cooke, T. D., E. R. Hurd, H. E. Jasin, J. Bienenstock, and M. Ziff. 1975. Identification of immunoglobulins and complement in rheumatoid articular collagenous tissues. Arthritis Rheum. 18: 541-551.
30. Vetto, A. A., M. Mannik, E. Zatarain-Rios, and M. H. Wener. 1990. Immune deposits in articular cartilage of patients with rheumatoid arthritis have a granular pattern not seen in osteoarthritis. Rheumatol. Int. 10: 13-19.
31. Mollnes, T. E., T. Lea, O. J. Mellbye, J. Pahle, O. Grand, and M. Harboe. 1986. Complement activation in rheumatoid arthritis evaluated by C3dg and the terminal complement complex. Arthritis Rheum. 29: 715-721.
32. Scrivo, R., M. Di Franco, A. Spadaro, and G. Valesini. 2007. The immunology of rheumatoid arthritis. Ann. N. Y. Acad. Sci. 1108: 312-322.
33. Manzo, A., and C. Pitzalis. 2007. Lymphoid tissue reactions in rheumatoid arthritis. Autoimmun. Rev. 7: 30-34.
34. Lundy, S. K., S. Sarkar, L. A. Tesmer, and D. A. Fox. 2007. Cells of the synovium in rheumatoid arthritis. T lymphocytes. Arthritis Res. Ther. 9: 202.
35. Stamp, L. K., M. J. James, and L. G. Cleland. 2004. Interleukin-17: the missing link between T-cell accumulation and effector cell actions in rheumatoid arthritis? Immunol. Cell Biol. 82: 1-9.
36. Imamura, F., H. Aono, T. Hasunuma, T. Sumida, H. Tateishi, S. Maruo, and K. Nishioka. 1998. Monoclonal expansion of synoviocytes in rheumatoid arthritis. Arthritis Rheum. 41: 1979-1986.
37. Liu, P., N.A. Jenkins, and N. G. Copeland. 2003. A highly efficient recombineeringbased method for generating conditional knockout mutations. Genome Res. 13: 476-484.
38. Nagy, A., J. Rossant, R. Nagy, W. Abramow-Newerly, and J. C. Roder. 1993. Derivation of completely cell culture-derived mice from early-passage embryonic stem cells. Proc. Natl. Acad. Sci. USA 90: 8424-8428.
39. Luo, H., T. Charpentier, X. Wang, S. Qi, B. Han, T. Wu, R. Terra, A. Lamarre, and J. Wu. 2011. Efnb1 and Efnb2 proteins regulate thymocyte development, peripheral T cell differentiation, and antiviral immune responses and are essential for interleukin-6 (IL-6) signaling. J. Biol. Chem. 286: 41135-41152.
40. Brand, D. D., K. A. Latham, and E. F. Rosloniec. 2007. Collagen-induced arthritis. Nat. Protoc. 2: 1269-1275.
41. Kojima, F., M. Kapoor, L. Yang, E. L. Fleishaker, M. R. Ward, S. U. Monrad, P. C. Kottangada, C. Q. Pace, J. A. Clark, J. G. Woodward, and L. J. Crofford. 2008. Defective generation of a humoral immune response is associated with a reduced incidence and severity of collagen-induced arthritis in microsomal prostaglandin E synthase-1 null mice. J. Immunol. 180: 8361-8368.
42. Smolen, J. S., D. Aletaha, and K. Redlich. 2012. The pathogenesis of rheumatoid arthritis: new insights from old clinical data? Nat Rev Rheumatol 8: 235-243.
43. McInnes, I. B., and G. Schett. 2011. The pathogenesis of rheumatoid arthritis. N. Engl. J. Med. 365: 2205-2219.
44. Brand, D. D., A. H. Kang, and E. F. Rosloniec. 2003. Immunopathogenesis of collagen arthritis. Springer Semin. Immunopathol. 25: 3-18.
45. Sheibanie, A. F., T. Khayrullina, F. F. Safadi, and D. Ganea. 2007. Prostaglandin E2 exacerbates collagen-induced arthritis in mice through the inflammatory interleukin-23/interleukin-17 axis. Arthritis Rheum. 56: 2608-2619.
46. Bouaziz, J.-D., K. Yanaba, G. M. Venturi, Y. Wang, R. M. Tisch, J. C. Poe, and T. F. Tedder. 2007. Therapeutic B cell depletion impairs adaptive and autoreactive CD4+ T cell activation in mice. Proc. Natl. Acad. Sci. USA 104: 20878-20883.
47. Pelletier, N., M. Casamayor-Pallejà, K. De Luca, P. Mondière, F. Saltel, P. Jurdic, C. Bella, L. Genestier, and T. Defrance. 2006. The endoplasmic reticulum is a key component of the plasma cell death pathway. J. Immunol. 176: 1340-1347.
48. Barrett, R., X. Zhang, H. W. Koon, M. Vu, J.-Y. Chang, N. Yeager, M. A. Nguyen, K. S. Michelsen, D. Berel, C. Pothoulakis, et al. 2012. Constitutive TL1A expression under colitogenic conditions modulates the severity and location of gut mucosal inflammation and induces fibrostenosis. Am. J. Pathol. 180: 636-649.
49. McInnes, I. B., and G. Schett. 2007. Cytokines in the pathogenesis of rheumatoid arthritis. Nat. Rev. Immunol. 7: 429-442.
50. Elgueta, R., M. J. Benson, V. C. de Vries, A. Wasiuk, Y. Guo, and R. J. Noelle. 2009. Molecular mechanism and function of CD40/CD40L engagement in the immune system. Immunol. Rev. 229: 152-172.
51. King, C., S. G. Tangye, and C. R. Mackay. 2008. T follicular helper (TFH) cells in normal and dysregulated immune responses. Annu. Rev. Immunol. 26: 741-766.